Supernus Pharmaceuticals Inc - Company Profile
Powered by 
All the sales intelligence you need on Supernus Pharmaceuticals Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Supernus Pharmaceuticals Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Supernus Pharmaceuticals Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Supernus Pharmaceuticals Inc (Supernus Pharmaceuticals) develops and commercializes products for the treatment of CNS diseases. Focused R&D activities, proprietary technologies, and lead product known as Qelbree are its major strengths, even as operational performance could be a cause for concern to the company. Positive outlook of the global pharmaceutical market, regulatory approvals, and acquisitions of Sage Therapeutics could present growth opportunities for the company. However, government regulations, growing labor costs in US, and competitive pressure could hamper its growth prospects.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer